These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19055588)

  • 41. When should an interim analysis be unblinded to the data monitoring committee?
    Knottnerus JA; Spigt MG
    J Clin Epidemiol; 2010 Apr; 63(4):350-2. PubMed ID: 19762210
    [No Abstract]   [Full Text] [Related]  

  • 42. Data monitoring (and safety) committees--what are they and why do we need them? Primary Care Alliance for Clinical Trials (PACT) Network.
    Pirotta M; Chondros P;
    Aust Fam Physician; 2004 Nov; 33(11):950-1, 956. PubMed ID: 15584339
    [No Abstract]   [Full Text] [Related]  

  • 43. Registering clinical trials in India: a scientific and ethical imperative.
    Tharyan P; Ghersi D
    Natl Med J India; 2008; 21(1):31-4. PubMed ID: 18472701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Data management for clinical trials at the data center].
    Niimi M; Fukuda H; Yamamoto S; Okuyama S; Yamaguchi N
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):253-9. PubMed ID: 9474934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Data monitoring committees. Third pillar in the methodical conduct of clinical trials].
    Fischer T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jul; 51(7):793-6. PubMed ID: 18563280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exploring the role and function of trial steering committees: results of an expert panel meeting.
    Harman NL; Conroy EJ; Lewis SC; Murray G; Norrie J; Sydes MR; Lane JA; Altman DG; Baigent C; Bliss JM; Campbell MK; Elbourne D; Evans S; Sandercock P; Gamble C
    Trials; 2015 Dec; 16():597. PubMed ID: 26715378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Planning and core analyses for periodic aggregate safety data reviews.
    Xia HA; Crowe BJ; Schriver RC; Oster M; Hall DB
    Clin Trials; 2011 Apr; 8(2):175-82. PubMed ID: 21270142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Data monitoring committees for multicenter clinical trials sponsored by the National Institutes of Health. I. Roles and membership of data monitoring committees for trials sponsored by the National Eye Institute.
    Hawkins BS
    Control Clin Trials; 1991 Jun; 12(3):424-37. PubMed ID: 1651212
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials.
    Fernandes RM; van der Lee JH; Offringa M
    BMC Pediatr; 2009 Dec; 9():77. PubMed ID: 20003383
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The German Clinical Trials Register: reasons, general and technical aspects, international integration].
    Dreier G; Hasselblatt H; Antes G; Schumacher M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Apr; 52(4):463-8. PubMed ID: 19308331
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Institution/investigator-initiated clinical trials in Canada.
    Sedgeworth J; Derewlany L
    Can J Clin Pharmacol; 2006; 13(2):e236-9. PubMed ID: 16873897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal.
    Dechartres A; Boutron I; Roy C; Ravaud P
    J Clin Epidemiol; 2009 Jul; 62(7):695-702. PubMed ID: 19135860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monitoring reportable events and unanticipated problems: the PHAROS and PREDICT studies of Huntington disease.
    Erwin C; Hersch S;
    IRB; 2007; 29(3):11-6. PubMed ID: 17847637
    [No Abstract]   [Full Text] [Related]  

  • 55. [The role of the biostatistician in biomedical research].
    Bangdiwala SI
    Rev Med Chil; 1999 Feb; 127(2):223-8. PubMed ID: 10436704
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Data safety monitoring boards: a word from a sponsor (NHLBI).
    Mondoro TH
    Transfusion; 2009 Aug; 49(8):1537-9. PubMed ID: 19413736
    [No Abstract]   [Full Text] [Related]  

  • 57. A Practical Guide to Data Monitoring Committees in Adaptive Trials.
    Sanchez-Kam M; Gallo P; Loewy J; Menon S; Antonijevic Z; Christensen J; Chuang-Stein C; Laage T
    Ther Innov Regul Sci; 2014 May; 48(3):316-326. PubMed ID: 30235541
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical trial registration.
    Harms M
    Physiotherapy; 2011 Sep; 97(3):181. PubMed ID: 21820534
    [No Abstract]   [Full Text] [Related]  

  • 59. History, objectivity, and the construction of molecular phylogenies.
    Suárez-Díaz E; Anaya-Muñoz VH
    Stud Hist Philos Biol Biomed Sci; 2008 Dec; 39(4):451-68. PubMed ID: 19026976
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guidelines for data and safety monitoring for clinical trials not requiring traditional data monitoring committees.
    ; Dixon DO; Freedman RS; Herson J; Hughes M; Kim K; Silverman MH; Tangen CM
    Clin Trials; 2006; 3(3):314-9. PubMed ID: 16895048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.